Company Description
Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases.
The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.
It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves.
The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally.
The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013.
Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Country | United States |
Founded | 1995 |
IPO Date | Oct 1, 2020 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 279 |
CEO | Steven Williamson |
Contact Details
Address: 700 Chesapeake Drive Redwood City, California 94063 United States | |
Phone | 650 364 0400 |
Website | pulmonx.com |
Stock Details
Ticker Symbol | LUNG |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $19.00 |
CIK Code | 0001127537 |
CUSIP Number | 745848101 |
ISIN Number | US7458481014 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Steven S. Williamson | Chief Executive Officer, President and Director |
Geoffrey Beran Rose | Chief Commercial Officer |
Mehul Joshi | Chief Financial Officer |
Sri Radhakrishnan | Chief Technical Officer |
Marcee M. Maroney | Vice President of Marketing |
Sarah Huber | Vice President of Sales (U.S.) |
Lisa Paul | Chief People Officer |
Jérôme Erath | Senior Vice President and GM of Europe Middle-East & Africa |
John B. McKune | Vice President and Corporate Controller |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 22, 2024 | 144 | Filing |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 8, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 1, 2024 | 10-Q | Quarterly Report |
Oct 30, 2024 | 8-K | Current Report |
Oct 17, 2024 | 144 | Filing |
Sep 12, 2024 | 144 | Filing |
Aug 2, 2024 | 10-Q | Quarterly Report |
Jul 31, 2024 | 8-K | Current Report |